Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Ping An Climbs to 21 in the Fortune Global 500 List, 2nd Among Global Financial Enterprises

Published

on

Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An” or the “Group”, HKEx:2318; SSE:601318) is number 21 overall in the 2020 Fortune Global 500 list, climbing eight places since last year. With sustained growth and revenues of USD184,280 million, the Group ranked second among global financial enterprises, fifth among all Chinese enterprises.

The Fortune Global 500 list is regarded as the most authoritative ranking for the world’s biggest listed companies, measured primarily by annual revenues and profits. This year, total revenue of the 500 global listed companies reached a record high of USD33 trillion. This year, the number of Chinese (including Hong Kong) enterprises reached 124, surpassing U.S. companies (121) for the first time.

Ping An achieved sustained business growth in 2019, as the Group further pursued its “finance + technology” and “finance + ecosystem” transformation strategies, and continued to enhance its data-driven operational capabilities.

In 2019, the Group’s revenue amounted to RMB1,168,867 million, up 19.7% year on year. Operating profit attributable to shareholders of the parent company rose 18.1% year on year to RMB132,955 million. Net profit attributable to shareholders of the parent company rose 39.1% year on year to RMB149,407 million. As of 31 December 2019, the Group’s total number of retail customers surpassed 200 million and internet users reached 516 million. The Group acquired 36.57 million new customers year-on-year, 40.7% of whom were sourced from internet users within the Group’s five ecosystems – financial services, health care, auto services, real estate services, and smart city services.

Ping An aims to “serve the real economy with finance”. Through its insurance, banking, trust and fintech businesses, the Group has allocated more than RMB4 trillion to economic and social development, including means such as insurance protection, loan provision, debt-equity plans and inclusive finance. For example, Ping An and the Guangdong provincial government jointly established the “Guangdong-Ping An Development Fund” of RMB150 billion, investing in large-scale infrastructure within the Guangdong-Hong Kong-Macao Greater Bay Area, including smart city construction, a high-speed railway, an inter-city railway and an airport. Loans for entities granted by Ping An Bank in 2019 reached RMB2.1 trillion, increasing by RMB153.6 billion compared to the end of 2018. Ping An Property & Casualty introduced a range of property, personnel and the third-party liability insurance products for small- and micro-sized enterprises, for protection against their most common risks.

With “finance + technology” as Ping An’s core and main businesses, the Group applies world-leading technologies in its main financial business to increase efficiency, cut costs and enhance risk management while offering customers excellent products and service experiences. Its innovations include the introduction of artificial intelligence (AI) interview robots in the Group’s life and health insurance unit to conduct 100% of sales agent recruitment interviews and the agents’ exclusive smart personal assistant AskBob, which has served agents 340 million times to date. Ping An Property & Casualty launched the Ping An Motor Insurance Trust Claim service, which has cut the average turnaround time of a single claim to three minutes and provides 45 million auto owners with a line of credit. In banking, Ping An developed AI-powered retail banking for all processes including sales, risk control, operations, and management. AI is also used to credit card approvals; of the 14.3 million credit cards issued by Ping An Bank in 2019, nearly 90% were automatically approved by AI.

Ping An’s technologies have also been widely applied to support its five ecosystems. By providing innovative products and services to the market, the Group’s technology business grew rapidly in 2019: total revenue increased by 27.1% year on year to RMB82,109 million. The total valuation of the technology companies reached USD69.1 billion. As of 31 December 2019, the Group had a technology team of nearly 110,000 technology business employees, 35,000 R&D employees, and 2,600 scientists. Ping An’s technology patent applications reached 21,383, and Ping An achieved global ranking of first in fintech and second in digital healthtech for the number of published patent applications.

Ping An is also pursuing sustainable development based on Environment, Social and Governance (ESG) principles. Its MSCI ESG rating has been upgraded twice in a row to “A”. Ping An also built an AI-ESG platform to empower responsible investment. As of 31 December 2019, the Group’s responsible investment reached RMB954,449 million, sustainable insurance insured amount reached RMB121.21 trillion, and the total line of green credit granted reached RMB59,056 million. Ping An is also continuing to drive its “Ping An Rural Communities Support” initiative in China, with RMB24,905 million in poverty alleviation funds granted to date. The Group has also supported the COVID-19 pandemic control efforts in China, with support measures such as insurance protection, medical support and external donations. The Group’s total amount of material and cash donations has exceeded RMB175 million.

In 2020, Ping An’s brand value continues to increase: the Group ranked 7th in Forbes Global 2000 list and 38th in BrandZ™ Top 100 Most Valuable Global Brands list, maintaining its top position among global insurance brands.

Other Chinese enterprises in the top 30 in the 2020 Fortune Global 500 list include Sinopec Group (2nd place), State Grid Corporation of China (3rd), China National Petroleum (4th), China State Construction Engineering (18th), Industrial and Commercial Bank of China (24th), Hon Hai Precision Industry (26th) and China Construction Bank (30th).

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending